Why the study?
What are the performance characteristics of quantitative point-of-care cardiac troponin devices in diagnosing myocardial infarction?
What are the performance characteristics of quantitative point-of-care cardiac troponin devices in diagnosing myocardial infarction?
Point-of-care cardiac troponin devices with a coefficient of variation ≤20% at the 99th percentile upper reference limit can provide clinically acceptable findings to assist in the rapid diagnosis of myocardial infarction.
Answers are grounded in this paper and cite their sources.
Select POC cTn devices may aid rapid MI diagnosis; leaves open prospective validation against central-lab assays.
Cardiac troponin (cTn) I and T are released from myocardial cells following necrosis, i.e., cell death. An accurate measure of cTn concentrations in a patient's blood following ischemia/chest pain can enable providers to determine whether or not a myocardial infarction (MI) has occurred. Point-of-care (POC) devices that measure blood cTn concentrations in under 30 min may help to significantly reduce hospital costs by managing and triaging patients out of the emergency department as quickly as possible. The use of POC devices that measure cTnI and cTnT with a coefficient of variation (CV) ≤20% at the 99th percentile upper reference limit (URL) limits both false positive and negative results and provides clinically acceptable findings to assist in appropriate diagnoses. This article reviews nine POC devices that measure cTn in terms of their clinical sensitivity and specificity, analytical imprecision, sample type and preparation, and each assay's principle of analysis.
No takes yet. Share an insight, caveat, or question.
Amundson et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: